apl. Prof. Dr. Christoph Daniel



Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-β activation (2009) Daniel C, Wagner A, Hohenstein B, Hugo C Journal article Correlation of enhanced thrombospondin-1 expression, TGF-β signalling and proteinuria in human type-2 diabetic nephropathy (2008) Hohenstein B, Daniel C, Hausknecht B, Boehmer K, Riess R, Amann KU, Hugo C Journal article HIF activation protects from acute kidney injury (2008) Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Campean V, Amann KU, et al. Journal article, Original article The mTOR inhibitor everolimus attenuates the time course of chronic anti-Thy1 nephritis in the rat (2008) Wittmann S, Daniel C, Braun A, Vogelbacher R, Shimizu F, Kawachi H, Hugo C Journal article Nestin expression in repopulating mesangial cells promotes their proliferation (2008) Daniel C, Albrecht H, Lüdke A, Hugo C Journal article Blocking of angiotensin II is more than blocking of transforming growth factor-β (2008) Daniel C Journal article PDE-5 inhibition impedes TSP-1 expression, TGF-β activation and matrix accumulation in experimental glomerulonephritis (2008) Hohenstein B, Daniel C, Wittmann S, Hugo C Journal article The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat (2007) Vogelbacher R, Wittmann S, Braun A, Daniel C, Hugo C Journal article, Original article Thrombospondin-1 is an endogenous activator of TGF-β in experimental diabetic nephropathy in vivo (2007) Daniel C, Schaub K, Amann KU, Lawler J, Hugo C Journal article Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice (2007) Daniel C, Amann KU, Hohenstein B, Bornstein P, Hugo C Journal article